Physiology and pathophysiology of male erectile dysfunction;Physiologie und pathophysiologie der erektilen dysfunktion

Wiener Medizinische Wochenschrift

Volumn 150, Issue 1-2, 2000, Pages 4-7

  Jungwirth, A ^a  

^a Urologische Universitatsklinik   (Austria)

Author keywords

Erectile dysfunction; Pathophysiology; Prostaglandin E1; TGF 1

Indexed keywords

AGING; ARTICLE; ERECTILE DYSFUNCTION; HUMAN; MALE; PATHOPHYSIOLOGY; PENIS ERECTION; SMOOTH MUSCLE TONE; TISSUE OXYGENATION;

ADULT; AGING; ELECTROPHYSIOLOGY; HUMANS; IMPOTENCE; MALE; NEUROPEPTIDES; NITRIC OXIDE SYNTHASE; PENILE ERECTION; PENIS; SEXUAL BEHAVIOR;

EID: 0034102368     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. (1) Andersson KE, Wagner G: Physiology of penile erection. Physiol Rev 1995;75:191.
2. (2) Basile G, Goldstein J, Malkevich D, Heineman J, Goldstein BH, Payton TR, Krane RJ, Levenson S, Goldstein I: Can self-injection therapy "cure" impotence? in Goldstein I, Lue TF (eds): The Role of Alprostadil in the Diagnosis and Treatment of Erectile Dysfunction. Princeton, Excerpta Medica, 1993, pp 109-116.
3. (3) Baum BJ, Moss J, Bruel SD, Berg RA, Crystal RG: Effect of cyclic AMP on the intracellular degradation of newly synthesized collagen. J Biol Chem 1980;255:2843-2847.
4. (4) Border WA, Ruoslahti E: Transforming growth factor-β in disease: the dark side of tissue repair. J Clin Inv 1992;90:1-7.
5. (5) Botney MD, Liptay MJ, Kaiser LR, Cooper JD, Parks WC, Mecham RP: Active collagen synthesis by pulmonary arteries in human primary pulmonary hypertension. Am J Pathol 1993;143:121-129.
6. (6) Burnett AL: Nitric oxide in the penis: physiology and pathology. J Urol 1997;157:320.
7. (7) Christ GJ, Maayani S, Valcic M, Melman A: Pharmacological studies of human erectile tissue: characteristics of spontaneouus contractions and alterations in (?adrenoceptor responsiveness with age and disease in isolated tissues. Brit J Pharmacol 1990;101:375.
8. (8) Christ GJ: The penis as a vascular organ. The importance of corporal smooth muscle tone in the control of erection. Urol Clin N Amer 1995;22:727.
9. (9) Christ GJ, Brink PR, Melman A, Spray DC: The role of gap junctions and ion channels in the modulation of electrical and chemical signals in human corpus cavernosum smooth muscle. Int J Impotence Res 1993;5:77.
10. (10) Fischer C, Gross J, Zuch J: Cycle of penile erections synchronous with dreaming (REM) sleep: preliminary report. Arch Gen Psychiatry 1965;12:29-45.
11. (11) Karacan I, Karatas M: Erectile dysfunction in sleep apnea and response to CPAP. Journal of Sex and Marital Therapy 1995;21: 239-247.
12. (12) Kim N, Vardi Y, Padma-Nathan H, Daley J, Goldstein I, Saenz de Tejada I: Oxygen tension regulates the nitric oxide pathway: Physiological role in penile erection. J Clin Invest 1993;91:437-443.
13. (13) Krane RJ, Goldstein I, Saenz de Tejada I: Impotence. Medical Progress. N Engl J Med 1989;321:1648-1659.
14. (14) Lamas S, Marsden PA, Li GK, Tempst P, Michel T: Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci 1992;89: 6348.
15. (15) Lawrence R, Hartmann DJ, Sonensheim GE: Transforming growth factor β stimulates type V collagen expression in bovine vascular smooth muscle cells. J Biol Chem 1994; 269:9603-9609.
16. (16) Lerner S, Melman A, Christ GJ: A review of erectile dysfunction: New insights and more questions. J Urol 1993;149(5 Part 2): 1246-1255.
17. (17) Lerner SE, Melman A, Christ GJ: A review of erectile dysfunction: new insights and more questions. J Urol 1993;149:1246.
18. (18) Lue TF, Tanagho EA: Physiology of erection and pharmacological management of impotence. J Urol 1987;137:829-836.
19. (19) Melman A, Gingell JC: The epidemiology and pathophysiology of erectile dysfunction. J Urol 1999;161:5-11.
20. (20) Mersdorf A, Goldsmith PC, Diederichs W, Padula CA, Lue TF, Fishman I J, Tanagho EA: Ultrastructural changes in impotent penile tissue: a gomparison of 65 patients. J Urol 1991;145:749-758
21. (21) Moreland RB: Is There a Role of Hypoxema in Penile Fibrosis? Int J Impotence Res 1998; 10:113-120.
22. (22) Moreland RB, Traish AM, McMillin MA, Smith B, Goldstein I, Saenz de Tejada I: PGEI suppresses the induction of collagen synthesis by transforming growth facotr-β1 in human corpus cavernosum smooth muscle. J Urol 1995;153:826-834.
23. β1 paradigm. J Urol 1996;155:679A(Abstract 1472).
24. (24) Nehra A, Goldstein I, Pabby A, Nugent M, Huang YH, de las Morenas A, Krane RJ, Udelson D, Saenz de Tejada I, Moreland RB: Mechanisms of venous leakage: a prospective clinicopathological correlation of corporeal function and structure. J Urol 1996;156: 1320-1329.
25. β1 induced corporal fibrosis: implications for penile ischemia-associated fibrosis. J Urol 1996;155:622A (Abstract 1243).
26. 1 in erectile failure: a survey of worldwide experience. J Urol 1996;155:802-815.
27. (27) Saenz de Tejada I, Carson MP, de las Morenas A, Golstein I, Traish AM: Endothelin: localization synthesis, activity and receptor types in human penile corpus cavernosum. Amer J Physiol 1991;26: H1078.
28. (28) Sporn MB, Roberts AB: Transforming growth factor-β: Recent progress and new challenges. J Cell Biol 1992;119:1017-1021.
29. 2 and to express cyclooxygenase-2. J Clin Inv 1995;95:1861-1868.
30. (30) Willis EA, Ottesen B, Wagner G, Sundler F, Fahrenkrug J: Vasoactive intestinal polypeptide (VIP) as a putative neurotransmitter in penile erection. Life Sci 1983;33:383.